Grenada vs Iraq: Cause of death, by non-communicable diseases, ages 0-4, female
Grenada
26.3%
in 2021
Iraq
25.7%
in 2021
Grenada rank
107th
Iraq rank
109th
Cause of death, by non-communicable diseases, ages 0-4, female over time
- Grenada
- Iraq
How they compare
Grenada currently reports 26.3% against 25.7% in Iraq, a difference of 0.6%.
The two have swapped places 2 times across 6 shared years of data; in 2000 it was Grenada ahead.
Grenada ranks 107th and Iraq ranks 109th of 185 countries.
Grenada has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Grenada | Iraq | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 15.0% | 13.6% | 1.5% | Grenada |
| 2010s | 27.7% | 19.8% | 7.9% | Grenada |
| 2020s | 26.3% | 25.6% | 0.7% | Grenada |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 0-4, female, Grenada or Iraq?
- Grenada, at 26.3% against 25.7% in Iraq as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 0-4, female between Grenada and Iraq?
- 0.6%, with Grenada ahead.
- How many years of comparable data are there for Grenada and Iraq?
- 6 years are reported by both, from 2000 to 2021.
- How do Grenada and Iraq rank globally for cause of death, by non-communicable diseases, ages 0-4, female?
- Grenada ranks 107th and Iraq ranks 109th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 0-4, female (% of total female deaths ages 0-4). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of female deaths ages 0-4 due to non-communicable diseases divided by number of all female deaths ages 0-4, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.